| ‘That would be dreadful’: The ethical, legal, and social challenges of sharing your Alzheimer’s disease biomarker and genetic testing results with others EA Largent, SD Stites, K Harkins, J Karlawish Journal of Law and the Biosciences 8 (1), lsab004, 2021 | 22 | 2021 |
| “A Raw Blessing”–Caregivers’ Experiences Providing Care to Persons Living with Dementia in the COVID-19 Pandemic EA Largent, A Peterson, K Harkins, C Coykendall, M Kleid, M Abera, ... Journal of Law, Medicine & Ethics 51 (3), 626-640, 2023 | | 2023 |
| A Case of Patient Abandonment, or an Abandonment of Patients? J Karlawish, A Peterson, JT Clapp, EA Largent The American Journal of Bioethics 22 (7), 86-87, 2022 | | 2022 |
| A framework for ethical payment to research participants L Gelinas, EA Largent, IG Cohen, S Kornetsky, BE Bierer, ... New England Journal of Medicine 378 (8), 766-771, 2018 | 184 | 2018 |
| A pragmatic, investigator-driven process for disclosure of amyloid PET scan results to ADNI-4 research participants CM Erickson, J Karlawish, JD Grill, K Harkins, SM Landau, ... The journal of prevention of Alzheimer's disease, 1-9, 2024 | | 2024 |
| A Pragmatic, Investigator-Driven Process for Disclosure of Amyloid PET Scan Results to ADNI-4 Research Participants. K Harkins, S Landau, M Rivera-Mindt, O Okonkwo, R Petersen, P Aisen, ... Journal of Prevention of Alzheimers Disease 11 (2), 2024 | | 2024 |
| A prescription for ethical learning EA Largent, FG Miller, S Joffe Hastings Center Report 43 (s1), S28-S29, 2013 | 28 | 2013 |
| Access to affordable medicines: obligations of universities and academic medical centers S Joffe, RM Conti, JL Contreras, EA Largent, HF Lynch, D Mitchell, ... Gene Therapy 30 (10), 753-755, 2023 | 4 | 2023 |
| Addressing financial barriers to enrollment in clinical trials EA Largent, HF Lynch JAMA oncology 4 (7), 913-914, 2018 | 17 | 2018 |
| Age-Based Vaccine Distribution Is Not Only Unethical. It’s Also Bad Health Policy. GC Persad, E Largent, EJ Emanuel | | 2021 |
| Algorithmic identification of persons with dementia for research recruitment: ethical considerations AJ London, J Karlawish, EA Largent, SP Hey, EP McCarthy Informatics for Health and Social Care, 1-14, 2024 | 1 | 2024 |
| Alzheimer’s in the modern age: Ethical challenges in the use of digital monitoring to identify cognitive changes CM Erickson, A Wexler, EA Largent Informatics for Health and Social Care 49 (1), 1-13, 2024 | | 2024 |
| Aspiring to reasonableness in accelerated approval: anticipating and avoiding the next aducanumab EA Largent, A Peterson, J Karlawish, HF Lynch Drugs & aging 39 (6), 389-400, 2022 | 10 | 2022 |
| Association between financial incentives and participant deception about study eligibility HF Lynch, S Joffe, H Thirumurthy, D Xie, EA Largent JAMA network open 2 (1), e187355-e187355, 2019 | 55 | 2019 |
| Attitudes toward physician-assisted death from individuals who learn they have an Alzheimer disease biomarker EA Largent, M Terrasse, K Harkins, DA Sisti, P Sankar, J Karlawish Jama Neurology 76 (7), 864-866, 2019 | 17 | 2019 |
| Bioethicists Today: Results of the Views in Bioethics Survey L Pierson, S Gibert, L Orszag, HK Sullivan, RY Fei, G Persad, EA Largent The American Journal of Bioethics, 1-16, 2024 | | 2024 |
| Bioethics’ Conceptual Tool Kit GE Kaebnick, L Haupt, J Chibbaro, N Berlinger, L Bruce, R Dresser, ... The Hastings Center report 53 (2), 1-1, 2023 | | 2023 |
| Blind peer review by academic journals EA Largent, RT Snodgrass Blinding as a solution to bias: strengthening biomedical science, forensic …, 2016 | 23 | 2016 |
| Blood biomarkers from research use to clinical practice: What must be done? A report from the EU/US CTAD Task Force D Angioni, J Delrieu, O Hansson, H Fillit, P Aisen, J Cummings, JR Sims, ... The journal of prevention of Alzheimer's disease 9 (4), 569-579, 2022 | 37 | 2022 |
| Bringing Alzheimer disease testing and results disclosure into the 21st Century Cures Act EA Largent, AR Bradbury JAMA neurology 79 (3), 219-220, 2022 | 10 | 2022 |
